This phase 3 multicenter study, which is coordinated by Cleveland Clinics C5Research academic research organization, is enrolling 15,000 adults with overweight or obesity (BMI 27) who do not have diabetes but do have either established CVD or multiple CVD risk factors
Key Takeaways MedVi charges $199$299/month for compounded GLP-1 medications through its online telehealth platform, with no insurance accepted Several alternatives cost less: Enhance.MD starts at $49 for the first month, Yucca Health from $169/month, and T-Mates offers no-hidden-fee flat pricing Insurance-friendly options exist: Found Health (free insurance check) and PlushCare work with health insurance, potentially saving $50$200+/month All providers offer compounded or brand-name GLP-1s: Semaglutide and tirzepatide are the most commonly prescribed across platforms Research-grade peptides offer another path: For laboratory and research use, GLP-1 compounds are available at significantly lower cost MedVi has grown into one of the more visible telehealth platforms for GLP-1 weight loss prescriptions, serving over 500,000 patients through its online portal and generating $1.6 billion in first-year sales
What are Semaglutide and Tirzepatide and their Role in Diabetes and Weight Loss/Management
Additionally, increased oxidative stress could lead to myocardial infarction (MI) in cardiac procedures
